ImmunoGen, Inc.
IMGNDelisted Feb 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000855654
ImmunoGen, Inc. was delisted on Feb 12, 2024; its insiders filed their last Form 4 on Feb 12, 2024; 327 institutions reported holding it in 13F filings for Q4 2023, worth $7.54B in total; Maverick Capital was the only superinvestor holding it.
Holders of 5% or more of IMGN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ImmunoGen, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of ImmunoGen, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on ImmunoGen, Inc., newest first.
No Schedule 13D or 13G filings on ImmunoGen, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell ImmunoGen, Inc. shares.
No Form 144 notices for ImmunoGen, Inc. are on file.